Friday, September 21, 2018

8:00-9:00

Registration of participants

9:00-9:15

Opening

Head of The Sanitary-epidemiological Department of MoH of  The Republic of Uzbekistan, Deputy Minister of the Ministry of health of The Republic of Uzbekistan S.S.Saidaliyev

9.15-11.20

Session 1. New technologies in the diagnosis, treatment and prevention of infectious diseases

The co-chairs: Musabaev E.I., Favorov M.O., Osmanov S., Granovsky N.N., Lopatukhin A.E.

9.15-9.35

Musabaev E.I. (Uzbekistan, Tashkent)

Reformation of patients with infection diseases assistance service in Uzbekistan. Innovative technologies part.

9.35-10.05

Favorov M.O. (USA, Atlanta)

Introduction of specific diagnosis of the socially significant diseases in the Republic of Uzbekistan in the format of "at the bedside" is the necessary link to enhance the role of General practitioners

10.05-10.35

Osmanov S. (Germany)
New approaches to screening, diagnosis and monitoring of antiviral therapy for HBV and HCV infection

10.35-11.05

Granovsky N.N. (Brazil)

Development of a modern therapeutic and prophylactic vaccine against hepatitis B (fourth generation) and an exclusive vaccine against hepatitis C

11.05-11.20

Lopatukhin A.E. (Russia, Moscow), Kazakova E. I. (Uzbekistan, Tashkent)

The prevalence of HIV drug resistance Eastern Europe and Central Asia countries. Monitoring program of HIV drug resistance in Uzbekistan.

11.20-13.00

Session 2. Immunization of infectious diseases

The co-chairs: Kostinov M.P., Chebotareva T.A., Tursunova D.A., Rakhimov R.A.

11.20-11.50

Kostinov M.P. (Russia, Moscow)

Practical issues of using influenza vaccines among individuals with normal and pathological anamnesis

11.50-12.10

Chebotareva T.A. (Russia, Moscow)

Epidemic season 2017-2018. How to help primary care pediatrician?

12.10-12.30

Rakhimov R.A., Ibadullaeva N.S., Rakhimov R.R. (Uzbekistan, Tashkent)

Characteristics of the incidence of influenza and other acute respiratory infections in Uzbekistan

12.30-13.00

Tursunova D.A. (Uzbekistan, Tashkent)

Immunization on practice. Challenges and successful cases of immunization program in Uzbekistan. Primary care physician role importance.

13.00-13.40

Lunch time

13.40-15.50

Session 3. New approaches in the treatment of infectious diseases

The co-chairs: Esaulenko E.V., Kamilov F.Kh., Kayumov U.K., Ariphodjaeva F. A.

13.40-14.00

Esaulenko E.V. (Russia, St. Petersburg)

Pathogenetic therapy of viral hepatitis

14.00-14.15

Rakhimova V.Sh. (Uzbekistan, Tashkent)

New approaches in the treatment of chronic hepatitis

14.15-14.40

Pulatova R.Z. (Uzbekistan, Tashkent)

Aspects of immunocorrection of acute respiratory infections of children

14.40-15.00

Kamilov F.Kh. (Uzbekistan, Tashkent)

New solutions in the treatment of chronic viral hepatitis

15.00-15.20

Kayumov U.K. (Uzbekistan, Tashkent)

Early diagnosis and effective rehabilitation of viral hepatitis in primary care

15.20-15.35

Ariphodjaeva F.A., Akalaev R.N., Abdushukurov A.A., Rashidova S.A., Abdullayev A.N. (Uzbekistan, Tashkent)

Chronic viral hepatitis in hospital hemodialysis departments

15.35-15.50

Dolimov Т.K., Gulyamov N.G. (Uzbekistan,Tashkent)

Glucocorticoid therapy in the treatment of severe viral hepatitis

15.50-16.50

WEBINAR

Pattapong Kessomboon (Thailand, Khon Kaen) 

Infectious diseases in primary health care. Experience of the Thailand professionals

16.50-17.50

Session 4. Discussion of the national standards for diagnosis and treatment of infectious diseases

The co-chairs: Ibadova G.A., Khudaykulova G.K.

16.50-17.05

Ibadova G.A. (Uzbekistan, Tashkent)

Standards of diagnosis, treatment and prevention of influenza and other acute respiratory viral infections of children. The position of evidence-based medicine

17.05-17.20

Khudaykulova G.K. (Uzbekistan, Tashkent)

Children's treatment standard of acute intestinal diseases in Uzbekistan

17.20-17.35

Rakhimova V.Sh., Kasimova R.I. (Uzbekistan, Tashkent)

New regulations on viral hepatitis.

17.35-17.50

Saidaliev S.S. (Uzbekistan, Tashkent)

National protocols for the treatment of Crimean-Congo hemorrhagic fever. Predictors of fatal outcome of CCHF

17.50-18.00

Discussion